Latest United States News

Volt Resources securities will resume trading after the company outlined a funding plan worth approximately A$6.912 million and confirmed its ongoing ASX compliance. The restart comes with two Tanzanian mining licences cancelled, limited reported cash and a proposed A$1.5 million capital raising yet to be structured.

FBR’s first Mantis welding robot has passed factory acceptance testing and independent weld inspections, removing the key condition on its sale to Industrial Robotics. The machine will remain in Perth for a paid customer pilot before heading to the United States, with a $198,000 deposit secured.

Imricor has completed FDA review of the largest module in its US Premarket Approval application, with no deficiencies found in its ablation catheter or irrigation tubing. One operating-system issue remains for the RF-5000 System, but the company says it has already updated the software and is preparing its response.

Servcorp Limited (ASX:SRV) has posted a third consecutive record year, with underlying profit, free cash flow and dividends all rising sharply. The debt-free workspace operator is guiding to another year of strong cash generation while investing in Saudi Arabia, technology and AI-enabled services.

InFocus is extending its Codexa platform from US sweepstakes gaming into licensed real-money online gambling markets, initially targeting Curaçao and crypto-native operators. Commercial availability is expected in early 2027, but the expansion still depends on product testing, regulatory registration and customer uptake.

Connexion Mobility has secured an exclusive supplier agreement with Hyundai Motor America to design, develop and manage a connected car-powered dealer lot platform across the United States. The strategic win adds a major OEM relationship, but its financial value and dealer uptake remain undisclosed.

The FDA says positive results from Neurizon’s HEALEY ALS trial could potentially support traditional approval of NUZ-001, with the study possibly serving as the sole registrational trial. The guidance is conditional, but gives the company a clearer regulatory route ahead of topline results expected in late Q2 2027.

RocketBoots has moved its major multinational retailer contract from integration into live US store installations, issuing its first €84,445 invoice for cloud activation and initial deployments. The milestone puts the company closer to accessing approximately A$9.1 million in annual recurring revenue, although the wider rollout remains phased and customer-led.

Stakk has secured a new IBM contract covering AI-powered document processing across Australia and New Zealand, with revenue contribution starting immediately. The agreement runs to September 2027, but its financial value remains unquantified because it depends on processing volumes.

Civmec has secured more than A$220 million in new contracts and extensions, including construction of Alcoa’s Wagerup gallium plant in Western Australia. The awards are scheduled for delivery across FY27 and FY28 and lift the order book to approximately A$1.5 billion.

OD6 Metals has secured A$6.92 million from institutional and sophisticated investors to advance drilling, bulk sampling and resource definition at its Quinn Fluorspar Project in Nevada. The funding also sets up a proposed rebrand to Adaven, but brings dilution and a substantial package of shareholder approvals.

AdAlta and Shanghai Cell Therapy Group have approved the FDA briefing pack and manufacturing transfer plan for EW-001, bringing the mesothelioma CAR-T therapy closer to an Australian Phase 1 trial. The FDA meeting is scheduled for November, while two Chinese patients remain under follow-up, including a second complete responder.